🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024
RATIONALE: Vaccines made from a person's tumor cells may help the body buil...
Status
Completed
Location
University of Miami Sylvester Comprehensive Cancer Center
Start Date
2007-05
Trial ID
NCT00503568
Treatments Being Tested
This study will test whether vaccination with viagenpumatucel-L combined wi...
Status
Completed
Location
University of Arizona Cancer Center
Start Date
2015-04-15
Trial ID
NCT02439450
Treatments Being Tested
NSCLC tumors are appropriate targets for active immunotherapy, because they...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-12
Trial ID
NCT01799161
Treatments Being Tested
This is a phase 1 open-label, single center, dose escalation study to deter...
Status
Completed
Location
Providence Portland Medical Center
Start Date
2019-10-18
Trial ID
NCT04116710
Treatments Being Tested